Skip to content
Dosage GuideResearch Reference

Insulin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Insulin. All information is for educational purposes only.

Quick Answer

Insulin dosages are highly individualized and depend on the type of insulin, individual insulin sensitivity, blood glucose levels, carbohydrate intake, and activity levels. Insulin therapy requires close medical supervision and self-monitoring of blood glucose. There are different types of insulin, each with a different onset and duration of action. Consult a healthcare professional for appropriate dosing.

→ Insulin Benefits→ Insulin Side Effects→ Full Insulin Profile
Table of Contents

Standard Dosage Range

Research dosing range: Highly individualized based on blood glucose monitoring and carbohydrate intake.

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Type 1 Diabetes

Variable, typically 0.5–1.0 units/kg/day initially, adjusted based on blood glucose monitoring.Multiple daily injections or continuous subcutaneous insulin infusion (CSII).
Duration

Lifelong.

Requires basal and bolus insulin. Basal insulin provides background coverage, while bolus insulin covers meals. Rapid-acting analogs are often used for bolus injections, and long-acting analogs for basal coverage.

Type 2 Diabetes

Variable, often starting with 0.1-0.2 units/kg/day or fixed low doses (e.g., 10 units daily), adjusted based on blood glucose monitoring.Once or twice daily injections, or multiple daily injections.
Duration

Variable, may be temporary or long-term.

Often used in combination with oral antidiabetic medications. Dosage is adjusted based on blood glucose levels and response to therapy.

Gestational Diabetes

Variable, typically starting with 0.7–1.0 units/kg/day in divided doses.Multiple daily injections.
Duration

During pregnancy.

Dosage is carefully adjusted to maintain optimal blood glucose control and minimize risks to the mother and fetus.

Hyperkalemia (Emergency Treatment)

5-10 units of regular insulin IV, with concurrent glucose administration.Single dose, as needed.
Duration

Single treatment.

Insulin drives potassium into cells, lowering serum potassium levels. Glucose is administered to prevent hypoglycemia.

Diabetic Ketoacidosis (DKA)

0.1 units/kg IV bolus followed by 0.1 units/kg/hr continuous IV infusion.Continuous infusion until DKA resolves.
Duration

Until resolution of DKA.

Requires close monitoring of blood glucose, electrolytes, and acid-base balance.

Timing & Frequency

Rapid-acting insulin analogs are injected 15 minutes before meals. Short-acting (regular) insulin is injected 30-60 minutes before meals. Intermediate-acting insulin (NPH) is typically injected once or twice daily. Long-acting insulin analogs are injected once daily at the same time each day. Ultra-long-acting insulin analogs are injected once daily.

Cycle Guidance

Insulin is generally used continuously for individuals with type 1 diabetes and may be used intermittently or continuously for individuals with type 2 or gestational diabetes, based on individual needs and medical advice. There is no cycling guidance for insulin because it replaces an essential hormone in type 1 diabetes or supplements insufficient hormone in type 2 diabetes.

Reconstitution Reference

Quick reference for reconstituting Insulin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 10 mL vials at 100 units/mL (U-100). Other concentrations (e.g., U-500) are available.
BAC Water VolumeNot applicable; insulin is supplied in a ready-to-use solution.
Concentration & Draw100 units/mL (U-100) is standard. U-500 is 500 units/mL.
StorageRefrigerate at 2–8°C (36–46°F). Do not freeze. Opened vials can be stored at room temperature (below 30°C or 86°F) for a limited time (typically 28 days) depending on the specific product.
StabilityUnopened vials are stable until the expiration date when refrigerated. Opened vials have limited stability at room temperature (typically 28 days).
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the difference between rapid-acting and long-acting insulin?
Rapid-acting insulin analogs (lispro, aspart, glulisine) have a rapid onset of action (15 minutes) and a short duration of action (3-5 hours), making them ideal for mealtime coverage. Long-acting insulin analogs (glargine, detemir, degludec) have a slow onset of action and a prolonged duration of action (up to 24 hours or longer), providing basal insulin coverage.
How is insulin dosage adjusted?
Insulin dosage is adjusted based on blood glucose monitoring, carbohydrate intake, activity levels, and other factors. It is essential to work with a healthcare professional to determine the appropriate insulin dosage and make necessary adjustments. Self-monitoring of blood glucose is crucial for effective insulin management.
What are the common side effects of insulin?
The most common side effect of insulin is hypoglycemia (low blood sugar). Other potential side effects include weight gain, injection site reactions (lipohypertrophy or lipoatrophy), and allergic reactions. It is important to be aware of these potential side effects and take appropriate steps to manage them.

Last updated: 2026-02-19